Mystery Solved: Scientists Discover Why Colorectal Cancer Defies Immune System Rules

Colorectal cancer breaks the usual immune rules, with certain regulatory T cells linked to improved survival. In many solid tumors, having a large number of regulatory T (Treg) cells is linked to ...
The Florida Times-Union

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell death through iron-dependent regulation. MIAMI, FL / ...
Medscape

Rucaparib Benefits HRD-Negative Ovarian Cancer Subgroups

Rucaparib maintenance therapy provided consistent benefits across all subgroups of patients grouped by prognostic factors of their homologous recombination deficiency-negative ovarian cancer tumors.

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. MIAMI, FLORIDA / ACCESS ...